title: Protective effect of melatonin on 3-NP induced striatal interneuron injury in rats.
abstract: To confirm the effect of melatonin on 3-nitropropionic acid (3-NP)-induced striatal interneuron injury in rats, behavioral test, histology, immunohistochemistry and Western blotting were respectively used to characterize the behavioral changes of experimental animals in motor and cognition, the morphological changes of striatal interneurons and the expression level of protein markers induced by 3-NP. The results showed that (1) 3-NP induced dysfunction of experimental animals in movement, motor coordination and cognition could be relieved by melatonin treatment; (2) The 3-NP-induced lesion area was unvaryingly in dorsolateral striatum, with almost all neuronal loss in the lesion core, however, lots of neurons survived after melatonin treatment; (3) Immunohistochemical staining of the four interneuron types (parvalbuminergic, cholinergic, calretinergic, and neuropeptide Y-neuronal nitric oxide synthase co-containing) showed that, in the lesion core of 3-NP group, loss of the four interneuron types was obvious, but in transition zone, the processes and varicosities of calretinergic, and neuropeptide Y-neuronal nitric oxide synthase co-containing interneurons increased significantly. Melatonin treatment reduced the loss of the four interneuron types in the lesion core, and inhibited the increase of processes and varicosities in the transition zone; (4) Consistent with above results, the expression level of five interneuron protein markers were significantly increased in the striatum after melatonin treatment. Notably, in both the transition zone and the lesion core induced by 3-NP, TUNEL-positive cells were detected, but decreased significantly after melatonin treatment. The present results indicate that melatonin effectively protects the striatal neurons against the injury induced by 3-NP in rats.
authors.affiliation: Department of Anatomy, Zhongshan School of Medicine, SUN Yat-sen University, Guangzhou 510080, China.
authors.forename: Shuhua
authors.initials: S
authors.lastname: Mu
authors.forename: Lisi
authors.initials: L
authors.lastname: OuYang
authors.forename: Bingbing
authors.initials: B
authors.lastname: Liu
authors.forename: Yaxi
authors.initials: Y
authors.lastname: Zhu
authors.forename: Keyi
authors.initials: K
authors.lastname: Li
authors.forename: Mali
authors.initials: M
authors.lastname: Zhan
authors.forename: Zongwei
authors.initials: Z
authors.lastname: Liu
authors.forename: Yu
authors.initials: Y
authors.lastname: Jia
authors.forename: Wanlong
authors.initials: W
authors.lastname: Lei
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D015153:Blotting, Western; D007150:Immunohistochemistry; D007395:Interneurons / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D009574:Nitro Compounds / Q000633:toxicity*; D011422:Propionates / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D009574:Nitro Compounds; D011422:Propionates; D008550:Melatonin; C015392:3-nitropropionic acid